Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production | Zendy

Remco Franssen | Zendy; Raaj R. Sankatsing | Zendy; Elly A. Hassink | Zendy; Barbara A. Hutten | Zendy; Mariëtte T. Ackermans | Zendy; Kees Brinkman | Zendy; René Oesterholt | Zendy; Alejandro ArenasPinto | Zendy; Stephen P. Storfer | Zendy; John J.P. Kastelein | Zendy; Hans P. Sauerwein | Zendy; Peter Reiss | Zendy; Erik S.G. Stroes | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production

Author(s) -

Remco Franssen,

Raaj R. Sankatsing,

Elly A. Hassink,

Barbara A. Hutten,

Mariëtte T. Ackermans,

Kees Brinkman,

René Oesterholt,

Alejandro ArenasPinto,

Stephen P. Storfer,

John J.P. Kastelein,

Hans P. Sauerwein,

Peter Reiss,

Erik S.G. Stroes

Publication year - 2009

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.109.192088

Subject(s) - nevirapine , apolipoprotein b , efavirenz , abacavir , cholesterol , medicine , endocrinology , high density lipoprotein , catabolism , lipoprotein , chemistry , pharmacology , biology , metabolism , viral load , human immunodeficiency virus (hiv) , immunology , antiretroviral therapy

The purpose of this study was to investigate the mechanism by which the nonnucleoside reverse transcriptase inhibitor (NNRTI) nevirapine (NVP) increases high-density lipoprotein cholesterol (HDLc) in treatment-experienced human immunodeficiency virus-1 (HIV-1)-infected patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research